Efficacy of Folrex in the Superior Extremity Rehabilitation After Acute Stroke
NCT01016119 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2010-03-08
Summary
The purpose of the study is to evaluate whether Folrex, could improve the motor recovery of the upper extremity after stroke in comparison with placebo during 4 weeks of treatment.
Conditions
Interventions
- DRUG
-
Folrex
Folrex cream, in the early rehabilitations in the upper extremity, before daily rehabilitation
- DRUG
-
Placebo cream, in the early rehabilitations in the upper extremity, before daily rehabilitation
Sponsors & Collaborators
-
Catalysis SL
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- Cuba
Study Locations
More Related Trials
-
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
NCT02422940 ·Status: TERMINATED ·Phase: PHASE3
-
Phase 3 Study of Dexpramipexole in ALS
NCT01281189 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days
NCT00964340 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Ropinirole in Motor Recovery After Stroke
NCT00221390 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets.
NCT02271217 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Determine the Safety, Pharmacokinetics, and Pharmacodynamics of DNL343 in Participants With Amyotrophic Lateral Sclerosis
NCT05006352 ·Status: COMPLETED ·Phase: PHASE1
-
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
NCT01083667 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study Exploring the PK/PD Relationship of QRL-101 in Adults With ALS
NCT06714396 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
NCT04577352 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
NCT01605825 ·Status: COMPLETED ·Phase: PHASE2
-
Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia
NCT02363075 ·Status: UNKNOWN ·Phase: PHASE3
-
A Clinical Pharmacology Study to Evaluate the Effect of GYM329 on Disuse Muscle Atrophy in Healthy Volunteer
NCT04708847 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00072709 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label, Safety and Tolerability Extension Study of KNS-760704 in Amyotrophic Lateral Sclerosis (ALS) (CL211)
NCT00931944 ·Status: COMPLETED ·Phase: PHASE2
-
A Long-term Extension Study of TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis(ALS)
NCT00230074 ·Status: COMPLETED ·Phase: PHASE2
-
NF-κB Inhibition in Amyotrophic Lateral Sclerosis
NCT05031351 ·Status: UNKNOWN ·Phase: PHASE2
-
A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS)
NCT03506425 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Study to Evaluate the Efficacy and Safety of FB1006 in the Treatment of ALS Patients
NCT05923905 ·Status: RECRUITING ·Phase: PHASE4
-
Colchicine for Amyotrophic Lateral Sclerosis
NCT03693781 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant
NCT03116997 ·Status: COMPLETED ·Phase: PHASE3
-
The KHENERGYC Study
NCT04846036 ·Status: SUSPENDED ·Phase: PHASE2
-
Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication
NCT00783081 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
NCT01921868 ·Status: UNKNOWN ·Phase: NA
-
A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis
NCT00036413 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Nitrazine in the Treatment of ALS
NCT04950647 ·Status: UNKNOWN ·Phase: PHASE2